Brief: Reshape Lifesciences Announces Pricing Of $3.0 Million Public Offering
Sept 29 (Reuters) - ReShape Lifesciences Inc RSLS.O :
* RESHAPE LIFESCIENCES® ANNOUNCES PRICING OF $3.0 MILLION
PUBLIC
OFFERING
* RESHAPE LIFESCIENCES INC - EACH UNIT IS BEING SOLD AT A
PUBLIC
OFFERING PRICE OF $0.33
Source text for Eikon: ID:nGNX4rFDnL
Further company coverage: RSLS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Vyome Holdings
See all newsBrief: Vyome - Appoints Jerry Leonard As CFO On August 27, 2026 - SEC Filing
Biopharma firm Vyome Holdings posts Q2 net loss
Vyome Holdings Inc reports results for the quarter ended June 30 - Earnings Summary
Vyome Holdings Inc expected to post a loss of 19 cents a share - Earnings Preview
Brief: Vyome Strikes Deal With Impetis Biosciences, Opening A ~$57B Market Opportunity